Temozolomide (TMZ). a DNA methylating agent. is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O6-methylguanine (O6mG) adducts. https://www.itsmajorlook.com/